Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Laurie Tomlinson and Liam Smeeth.
Laurie Tomlinson
Connection Strength
2.764
Liam Smeeth
  1. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. BMJ. 2021 03 18; 372:n628.
    View in: PubMed
    Score: 0.234
  2. Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Res. 2020; 5:77.
    View in: PubMed
    Score: 0.220
  3. Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. 2018; 10:1639-1648.
    View in: PubMed
    Score: 0.199
  4. Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom. Clin Epidemiol. 2018; 10:421-429.
    View in: PubMed
    Score: 0.191
  5. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018 02 09; 360:k341.
    View in: PubMed
    Score: 0.189
  6. Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis. Clin Epidemiol. 2018; 10:187-202.
    View in: PubMed
    Score: 0.188
  7. Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study. BMJ Open. 2017 Nov 16; 7(11):e018153.
    View in: PubMed
    Score: 0.186
  8. Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ. 2017 Mar 09; 356:j791.
    View in: PubMed
    Score: 0.177
  9. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study. BMJ Open. 2017 01 09; 7(1):e012818.
    View in: PubMed
    Score: 0.175
  10. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ Open. 2016 12 21; 6(12):e012690.
    View in: PubMed
    Score: 0.174
  11. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021 11; 71(712):e806-e814.
    View in: PubMed
    Score: 0.061
  12. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021 07 14; 374:n1592.
    View in: PubMed
    Score: 0.060
  13. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur. 2021 Jul; 6:100109.
    View in: PubMed
    Score: 0.059
  14. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021 05 08; 397(10286):1711-1724.
    View in: PubMed
    Score: 0.059
  15. Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report. Wellcome Open Res. 2021; 6:90.
    View in: PubMed
    Score: 0.059
  16. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill. 2021 03; 26(11).
    View in: PubMed
    Score: 0.058
  17. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021 Mar; 3(3):e172-e173.
    View in: PubMed
    Score: 0.058
  18. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 07; 80(7):943-951.
    View in: PubMed
    Score: 0.058
  19. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol. 2021 Jan; 3(1):e19-e27.
    View in: PubMed
    Score: 0.057
  20. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020 11; 8(11):1106-1120.
    View in: PubMed
    Score: 0.057
  21. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 08; 584(7821):430-436.
    View in: PubMed
    Score: 0.056
  22. Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data. Br J Gen Pract. 2018 Aug; 68(673):e512-e523.
    View in: PubMed
    Score: 0.049
  23. Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study. Br J Clin Pharmacol. 2018 09; 84(9):2142-2151.
    View in: PubMed
    Score: 0.048
  24. A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes. Wellcome Open Res. 2018; 3:74.
    View in: PubMed
    Score: 0.048
  25. Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort. PLoS Med. 2017 Nov; 14(11):e1002457.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.